Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Merck Invests $41 Million in Its Italian Biotech Manufacturing Site of Bari
Introduction Merck will invest $41 million in a new production line for the aseptic filling of biotech medicines under isolator at its manufacturing site of Bari, Italy Features The new production is expected to be fully operational in 2022 and it will be equipped with an isolator designed with the latest technologies and with a high level...
Nitto Denko Avecia Announces Opening of Manufacturing Expansion in Milford, MA
Introduction Nitto Denko Avecia Inc Avecia announced the opening of its new oligonucleotide API active pharmaceutical ingredients manufacturing facility in Milford, MA Features The opening of the manufacturing facility will take place in 2017 onsite at the Milford, MA facility This expansion will help Avecias clients to receive timely o...
ImmunoPrecise Antibodies Announces New Antibody Production Laboratory at Vancouver Island Technology Park
Introduction ImmunoPrecise Antibodies announced the opening of its new 3,200 square foot state of the art antibody production laboratory at Vancouver Island technology Park Features The production laboratory has been designed in conjunction with Low Hammond Rowe Architects Architectural and engineering features enhance the workflow and cle...
Natco Pharma Plans $75 Million Expansion Project in Telangana, India
Introduction Natco Pharma plans to increase the production capacity and research development activity at Rangareddy plant in Telangana, India that would generate 1, 500 jobs Features Natco Pharma plans to increase the production capacity and research development activity at Rangareddy plant in Telangana The proposal is to increase the...
CARsgen Announces Opening of CAR-T Cell Manufacturing Facility in Shanghai
Introduction Shanghaibased CARsgen Therapeutics Carsgen announced the opening of CART cell manufacturing facility in Shanghai to support CARsgen clinical programs Features CART cell manufacturing facility is in strict compliance with current good manufacturing procedure cGMP regulations of China Food and Drug Administration CFDA The 33,...
Novasep Invests US$30 million to Build Viral Vector Production Facility
Introduction Novasep announced a strategic investment of US$30 million for a commercial scale production facility of viral vectors Features The new facility will be built at Novasep in Seneffe, Belgium to complement the existing labscale suites of the neighbouring site in Gosselies The site will feature two cGMP suites on 2000 sqm equip...
Sanofi and Lonza to Build New US$285 million Swiss Biologics Facility
Introduction Sanofi, French drugmaker and Swiss manufacturer Lonza will invest US$285 million to build a new largescale biologics facility that will produce monoclonal antibodies by 2020 Features The companies will build and operate a largescale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland The...
Allergan Expands its Dublin and Co Mayo Manufacturing Facilities Investing USD$45m
Introduction Botox maker Allergan has announced an addition USD$45m in its Irish Operations This helps to expand existing manufacturing capacity in Dublin and Co Mayo Features The additional money will be invested in Allergens manufacturing facilities in Westport and Clonshaugh and will sup
Edge Pharmacy Services Announces US$ 1.5m Expansion of its Manufacturing Facility
Introduction Edge Pharmacy Services invests US$ 15 Million to expand its manufacturing capabilities to include an additional 20, 000 square feet of space Features Edge is known manufacturing a wide variety of compounded pharmaceuticals with specific focuses in operating
Pfizer Plans US $100m Expansion of Company’s Drug Development Plant in Sanford, USA
Introduction Pfizer, the Global drug manufacturer is planning a potential US $100 million expansion of the companys drug development plant in Sanford Features Expansion of Pfizer drug development plant would include the addition of 50 new jobs if the company opts t
